SANOFI (SAN.PA) Fundamental Analysis & Valuation

EPA:SAN • FR0000120578

Current stock price

77.79 EUR
-0.36 (-0.46%)
Last:

This SAN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SAN.PA Profitability Analysis

1.1 Basic Checks

  • SAN had positive earnings in the past year.
  • SAN had a positive operating cash flow in the past year.
  • Each year in the past 5 years SAN has been profitable.
  • Each year in the past 5 years SAN had a positive operating cash flow.
SAN.PA Yearly Net Income VS EBIT VS OCF VS FCFSAN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • SAN has a Return On Assets of 9.85%. This is in the better half of the industry: SAN outperforms 69.23% of its industry peers.
  • SAN's Return On Equity of 17.49% is fine compared to the rest of the industry. SAN outperforms 61.54% of its industry peers.
  • SAN's Return On Invested Capital of 13.76% is fine compared to the rest of the industry. SAN outperforms 65.38% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SAN is significantly below the industry average of 14.90%.
  • The 3 year average ROIC (7.41%) for SAN is below the current ROIC(13.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROIC 13.76%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
SAN.PA Yearly ROA, ROE, ROICSAN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • With a decent Profit Margin value of 17.71%, SAN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
  • SAN's Profit Margin has declined in the last couple of years.
  • SAN's Operating Margin of 23.28% is in line compared to the rest of the industry. SAN outperforms 57.69% of its industry peers.
  • SAN's Operating Margin has improved in the last couple of years.
  • SAN's Gross Margin of 72.55% is in line compared to the rest of the industry. SAN outperforms 51.92% of its industry peers.
  • SAN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
SAN.PA Yearly Profit, Operating, Gross MarginsSAN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. SAN.PA Health Analysis

2.1 Basic Checks

  • SAN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for SAN has been reduced compared to 1 year ago.
  • SAN has less shares outstanding than it did 5 years ago.
  • SAN has a worse debt/assets ratio than last year.
SAN.PA Yearly Shares OutstandingSAN.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
SAN.PA Yearly Total Debt VS Total AssetsSAN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SAN has a debt to FCF ratio of 1.86. This is a very positive value and a sign of high solvency as it would only need 1.86 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 1.86, SAN belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
  • A Debt/Equity ratio of 0.22 indicates that SAN is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.22, SAN is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Altman-Z N/A
ROIC/WACC1.68
WACC8.2%
SAN.PA Yearly LT Debt VS Equity VS FCFSAN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.3 Liquidity

  • SAN has a Current Ratio of 1.09. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.09, SAN is doing worse than 73.08% of the companies in the same industry.
  • SAN has a Quick Ratio of 1.09. This is a normal value and indicates that SAN is financially healthy and should not expect problems in meeting its short term obligations.
  • SAN has a Quick ratio of 1.09. This is comparable to the rest of the industry: SAN outperforms 53.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
SAN.PA Yearly Current Assets VS Current LiabilitesSAN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. SAN.PA Growth Analysis

3.1 Past

  • SAN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 1.82%.
  • Measured over the past 5 years, SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.58% on average per year.
  • Looking at the last year, SAN shows a small growth in Revenue. The Revenue has grown by 5.29% in the last year.
  • The Revenue has been growing slightly by 4.57% on average over the past years.
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%

3.2 Future

  • Based on estimates for the next years, SAN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.49% on average per year.
  • The Revenue is expected to grow by 5.29% on average over the next years.
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SAN.PA Yearly Revenue VS EstimatesSAN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
SAN.PA Yearly EPS VS EstimatesSAN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. SAN.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.95, the valuation of SAN can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of SAN indicates a rather cheap valuation: SAN is cheaper than 84.62% of the companies listed in the same industry.
  • SAN is valuated cheaply when we compare the Price/Earnings ratio to 25.73, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 9.18 indicates a reasonable valuation of SAN.
  • 86.54% of the companies in the same industry are more expensive than SAN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.72. SAN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.95
Fwd PE 9.18
SAN.PA Price Earnings VS Forward Price EarningsSAN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SAN indicates a somewhat cheap valuation: SAN is cheaper than 69.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.21
EV/EBITDA N/A
SAN.PA Per share dataSAN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • SAN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • SAN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.18
PEG (5Y)1.78
EPS Next 2Y6.95%
EPS Next 3Y8.43%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. SAN.PA Dividend Analysis

5.1 Amount

  • SAN has a Yearly Dividend Yield of 5.38%, which is a nice return.
  • Compared to an average industry Dividend Yield of 1.92, SAN pays a better dividend. On top of this SAN pays more dividend than 88.46% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, SAN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.38%

5.2 History

  • The dividend of SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years6
Div Non Decr Years6
SAN.PA Yearly Dividends per shareSAN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • SAN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y6.95%
EPS Next 3Y8.43%
SAN.PA Yearly Income VS Free CF VS DividendSAN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

Find the best dividend stocksShow peers with best dividend

SAN.PA Fundamentals: All Metrics, Ratios and Statistics

SANOFI

EPA:SAN (3/20/2026, 5:36:15 PM)

77.79

-0.36 (-0.46%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners46.23%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap187.88B
Revenue(TTM)70.49B
Net Income(TTM)12.49B
Analysts76
Price Target98.37 (26.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.38%
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DPN/A
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.22%
Min EPS beat(2)4.58%
Max EPS beat(2)5.86%
EPS beat(4)3
Avg EPS beat(4)3.54%
Min EPS beat(4)-2.29%
Max EPS beat(4)6.02%
EPS beat(8)6
Avg EPS beat(8)4.07%
EPS beat(12)8
Avg EPS beat(12)3.12%
EPS beat(16)11
Avg EPS beat(16)3.47%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-2.08%
Max Revenue beat(2)-1.3%
Revenue beat(4)0
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-2.08%
Max Revenue beat(4)-0.63%
Revenue beat(8)2
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)14.42%
PT rev (1m)-1.76%
PT rev (3m)-8.6%
EPS NQ rev (1m)-0.84%
EPS NQ rev (3m)5.74%
EPS NY rev (1m)0.29%
EPS NY rev (3m)-1.32%
Revenue NQ rev (1m)-0.65%
Revenue NQ rev (3m)-2.21%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 9.95
Fwd PE 9.18
P/S 2.67
P/FCF 17.21
P/OCF 17.21
P/B 2.63
P/tB 49.25
EV/EBITDA N/A
EPS(TTM)7.82
EY10.05%
EPS(NY)8.48
Fwd EY10.9%
FCF(TTM)4.52
FCFY5.81%
OCF(TTM)4.52
OCFY5.81%
SpS29.19
BVpS29.55
TBVpS1.58
PEG (NY)1.18
PEG (5Y)1.78
Graham Number72.11
Profitability
Industry RankSector Rank
ROA 9.85%
ROE 17.49%
ROCE 16.67%
ROIC 13.76%
ROICexc 14.92%
ROICexgc 58.3%
OM 23.28%
PM (TTM) 17.71%
GM 72.55%
FCFM 15.49%
ROA(3y)4.87%
ROA(5y)5.28%
ROE(3y)8.47%
ROE(5y)9.13%
ROIC(3y)7.41%
ROIC(5y)7.45%
ROICexc(3y)8.06%
ROICexc(5y)8.26%
ROICexgc(3y)31.82%
ROICexgc(5y)35.77%
ROCE(3y)8.99%
ROCE(5y)9.04%
ROICexgc growth 3Y-8.07%
ROICexgc growth 5Y1.04%
ROICexc growth 3Y-0.36%
ROICexc growth 5Y3.93%
OM growth 3Y-0.84%
OM growth 5Y1.78%
PM growth 3Y-3.21%
PM growth 5Y-12.66%
GM growth 3Y1.06%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.86
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 87.43%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z N/A
F-Score5
WACC8.2%
ROIC/WACC1.68
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)127.25%
Profit Quality(5y)123.49%
High Growth Momentum
Growth
EPS 1Y (TTM)1.82%
EPS 3Y-1.77%
EPS 5Y5.58%
EPS Q2Q%16.79%
EPS Next Y8.41%
EPS Next 2Y6.95%
EPS Next 3Y8.43%
EPS Next 5Y8.49%
Revenue 1Y (TTM)5.29%
Revenue growth 3Y0.97%
Revenue growth 5Y4.57%
Sales Q2Q%7%
Revenue Next Year6.58%
Revenue Next 2Y6.19%
Revenue Next 3Y5.8%
Revenue Next 5Y5.29%
EBIT growth 1Y7.73%
EBIT growth 3Y0.11%
EBIT growth 5Y6.43%
EBIT Next Year28.69%
EBIT Next 3Y14.49%
EBIT Next 5Y9.74%
FCF growth 1Y85.47%
FCF growth 3Y9.46%
FCF growth 5Y15.4%
OCF growth 1Y20.22%
OCF growth 3Y1.22%
OCF growth 5Y8.03%

SANOFI / SAN.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SANOFI?

ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.


Can you provide the valuation status for SANOFI?

ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for SANOFI?

SANOFI (SAN.PA) has a profitability rating of 6 / 10.


What is the valuation of SANOFI based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 9.95 and the Price/Book (PB) ratio is 2.63.


How financially healthy is SANOFI?

The financial health rating of SANOFI (SAN.PA) is 5 / 10.